NMPA Approval

Group A and Group C Meningococcal Conjugate Vaccine

Approval Number

国药准字S20210018

Registration Date

June 22, 2021

Drug Information

Generic Name

A群C群脑膜炎球菌多糖结合疫苗

Trade Name

美奈喜/Menphecia

Dosage Form

注射剂

Strength

按标示量复溶后每瓶0.5ml，每1次人用剂量0.5ml，含A群结合多糖10μg，C群结合多糖10μg。

Drug Type

生物制品

Registration Date

June 22, 2021

Company Address

天津经济技术开发区西区南大街185号西区生物医药园四层401-420

Company Address

天津市滨海新区开发西区新桂路16号

Empowering clinical research with data-driven insights and AI-powered tools.

A群C群脑膜炎球菌多糖结合疫苗 - NMPA 批准文号 | MedPath